Arnold Ventures Profile picture
Apr 16, 2020 22 tweets 8 min read Read on X
#COVID19 has underscored the health care affordability crisis facing Americans & the need for #surprisebilling protections. Congress has already developed effective bipartisan compromise solutions that can be enacted now. (Thread)
arnoldventures.org/stories/debunk… @MarkMiller_DC @a_spratt
President Trump said providers receiving funds from the $100 billion #COVID19 bailout fund must refrain from #surprisebilling, but questions remain on implementation, and even with that, major gaps in patient protections remain.
A small subset of providers engage in #surprisebilling. They are often generated by private equity-owned physician groups who charge patients 500-800% more than Medicare rates for out-of-network services.
This was price gouging before #COVID19.
At the same time, these same firms are laying off providers or cutting their pay — while simultaneously asking for federal funding from the hospital bailout fund. propublica.org/article/medica…
Congress needs to enact legislation that:
-Prohibits all providers from directly billing insured patients.
-Limits what these providers are paid when they present their surprise bill to the insurer. #surprisebilling
The most effective approach is a payment benchmark requiring insurers to pay providers a local, market-based rate, resulting in savings to consumers, employers, and taxpayers — and already included in several bipartisan bills that advanced out of House and Senate committees.
Opponents to this approach have asserted a number of myths about surprise billing and this proposed solution. Let's debunk those:
Myth 1: Insurance companies — more than any other group — stand to benefit from the windfall in savings that would result from establishing a locally-based market rate for out-of-network care.
Reality: The savings from a benchmark approach would lead to lower premiums for consumers and employers, higher wages for families, and savings to taxpayers.
#Surprisebillng has inflated premiums by more than 3 percent, roughly a $40 billion increase in health care costs annually, according to research by @zackcooperYale and colleagues.
And the link between health care premiums and wages has been well-established:
nber.org/papers/w5525.p…
nber.org/papers/w11160.…
Private equity firms reap so much in profits from #surprisebilling that they have engaged in an aggressive $53 million lobbying and ad campaign to stop Congressional action: politico.com/news/2020/01/0…
Myth 2: Using a locally-based market rate to end #surprisebilling would massively disrupt the health care system, resulting in clinician shortages and potentially even hospital closures.
Reality: Even the proposals with the largest spending reductions affect only a small share of overall provider revenues and the subset of physicians who routinely engage in #surprisebilling. These physicians would be paid reasonable, market-based rates.
Surprise bills are a small fraction of business for most hospitals and providers, and current proposals do not cut funding to federal health care programs such as Medicare, Medicaid, and the Children’s Health Insurance Program.
Myth 3: The benchmark approach uses “government rate-setting” to fix surprise billing.
Reality: Current solutions to fix surprise billing rely on market rates set through negotiations between providers and insurers to determine the payment for out-of-network services.
Surprise billing has arisen from a clear market failure. Providers are highly consolidated with significant market power. Some, often backed by private equity, gain additional leverage by remaining out-of-network and “balance billing” patients.
A locally-based market rate would reflect local market forces and in-network rates and add a level of certainty and predictability to payment for out-of-network care for insurers (who will build uncertainty into rates), providers, and American families.
The alternative solution pushed by some providers — arbitration — adds more complexity, uncertainty and bureaucracy, resulting in increased administrative costs that will be paid by consumers, employers, and taxpayers.
.@MarkMiller_DC, @a_spratt and Erica Socker explore these myths and realities in more detail here: arnoldventures.org/stories/debunk… @a_spratt @MarkMiller_DC
It's time for Congress to finally act — in the face of a pandemic — for American families and taxpayers. Protections are needed now more than ever for all patients. arnoldventures.org/stories/debunk…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Arnold Ventures

Arnold Ventures Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Arnold_Ventures

Jun 1, 2021
44% of people sentenced to jail have a diagnosed mental illness
63% have a substance use disorder
45% suffer from chronic health problems

Jail often makes these conditions worse.

So how should cities respond to people in crisis? With data-driven justice. 1/
Today @Arnold_Ventures released the final reports from a multiyear pilot site test of using coordination and data to divert people in crisis away from jails and toward the services they need, such as healthcare or housing. 2/
These documents are three years in the making. Each site released its own final report that delves into how they used power of data to understand and better address the needs of frequent utilizers. 3/
Read 10 tweets
Oct 8, 2020
As the nation grapples with unemployment & state budgets shrink amid #COVID-19, Nevada has a model that policy officials could implement and test to reemploy dislocated workers: It’s helping millions find jobs faster AND saving state money. arnoldventures.org/stories/nevada… #VPDebates
#COVID19 is also exacerbating our nation's retirement crisis in a very different way than the Great Recession: washingtonpost.com/business/2020/… #VPDebate
The case of #BreonnaTaylor is evidence that America’s social contract is in tatters. @sdpjohnson explains our current reckoning: arnoldventures.org/stories/to-our… #VPDebate
Read 13 tweets
Oct 1, 2020
“I’m so grateful for #Gleevec. It keeps me alive. But the price tag ($10k/month) constantly hangs over my head.”
"When I'm on Enbrel, I don't have symptoms... But I also have to carry the fear knowing all this could be ripped away." Enbrel is priced at $6k per month.
First up: autoimmune drug Enbrel. Even though the primary patent on Enbrel expired in 2010, $AMGN has filed more than 50 additional patents on the drug to thwart cheaper competition, according to analysis by @IMAKglobal (1/) statnews.com/2020/09/29/dru…
Read 45 tweets
Sep 30, 2020
Medicare spent hundreds of millions of $$$ more on Copaxone each year because of its inability to negotiate directly @46brooklyn @akesselheim
Even Teva’s own employees could not afford Copaxone at its price. One said she could no longer afford Copaxone because she would have to pay $1,673.33 out of pocket as compared to $12 for Mylan’s generic product.
After Mylan introduced a lower-priced generic version of Copaxone 40 mg/ml in October 2017, Teva implemented several new exclusionary tactics to limit generic competition and maintain profits.
Read 4 tweets
Sep 30, 2020
First up: #Revlimid, a drug that costs $20k for a 28-day supply. The Committee reviewed more than 50k pages of internal communications & data from 2009 to now. Since Revlimid launched in '05, Celgene raised the price 22 times (1/) oversight.house.gov/sites/democrat…
After Bristol Myers Squibb obtained the rights to Revlimid last November, it raised the price again to $763/pill. The price has tripled in 15 years (2/)
Revlimid is a textbook case of profits over patients (3/)
Read 8 tweets
Sep 24, 2020
Pres. Trump, touting his record on drug prices, pledges to issue $200 cards to all seniors. Reality check 👇
1) The legal authority to issue these cards is questionable, at best.
2) Pres. Trump's recently issued executive orders will do nothing to lower drug prices immediately.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(